Cargando…

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine

AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Amic, Fedor, Drmic, Domagoj, Bilic, Zdenko, Krezic, Ivan, Zizek, Helena, Peklic, Marina, Klicek, Robert, Pajtak, Alen, Amic, Enio, Vidovic, Tinka, Rakic, Mislav, Milkovic Perisa, Marija, Horvat Pavlov, Katarina, Kokot, Antonio, Tvrdeic, Ante, Boban Blagaic, Alenka, Zovak, Mario, Seiwerth, Sven, Sikiric, Predrag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305534/
https://www.ncbi.nlm.nih.gov/pubmed/30598581
http://dx.doi.org/10.3748/wjg.v24.i47.5366
_version_ 1783382587424636928
author Amic, Fedor
Drmic, Domagoj
Bilic, Zdenko
Krezic, Ivan
Zizek, Helena
Peklic, Marina
Klicek, Robert
Pajtak, Alen
Amic, Enio
Vidovic, Tinka
Rakic, Mislav
Milkovic Perisa, Marija
Horvat Pavlov, Katarina
Kokot, Antonio
Tvrdeic, Ante
Boban Blagaic, Alenka
Zovak, Mario
Seiwerth, Sven
Sikiric, Predrag
author_facet Amic, Fedor
Drmic, Domagoj
Bilic, Zdenko
Krezic, Ivan
Zizek, Helena
Peklic, Marina
Klicek, Robert
Pajtak, Alen
Amic, Enio
Vidovic, Tinka
Rakic, Mislav
Milkovic Perisa, Marija
Horvat Pavlov, Katarina
Kokot, Antonio
Tvrdeic, Ante
Boban Blagaic, Alenka
Zovak, Mario
Seiwerth, Sven
Sikiric, Predrag
author_sort Amic, Fedor
collection PubMed
description AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 μg, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 μg/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum. RESULTS: Unlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other’s response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues. CONCLUSION: BPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation.
format Online
Article
Text
id pubmed-6305534
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-63055342018-12-31 Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine Amic, Fedor Drmic, Domagoj Bilic, Zdenko Krezic, Ivan Zizek, Helena Peklic, Marina Klicek, Robert Pajtak, Alen Amic, Enio Vidovic, Tinka Rakic, Mislav Milkovic Perisa, Marija Horvat Pavlov, Katarina Kokot, Antonio Tvrdeic, Ante Boban Blagaic, Alenka Zovak, Mario Seiwerth, Sven Sikiric, Predrag World J Gastroenterol Basic Study AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 μg, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 μg/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum. RESULTS: Unlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other’s response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues. CONCLUSION: BPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation. Baishideng Publishing Group Inc 2018-12-21 2018-12-21 /pmc/articles/PMC6305534/ /pubmed/30598581 http://dx.doi.org/10.3748/wjg.v24.i47.5366 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Amic, Fedor
Drmic, Domagoj
Bilic, Zdenko
Krezic, Ivan
Zizek, Helena
Peklic, Marina
Klicek, Robert
Pajtak, Alen
Amic, Enio
Vidovic, Tinka
Rakic, Mislav
Milkovic Perisa, Marija
Horvat Pavlov, Katarina
Kokot, Antonio
Tvrdeic, Ante
Boban Blagaic, Alenka
Zovak, Mario
Seiwerth, Sven
Sikiric, Predrag
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title_full Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title_fullStr Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title_full_unstemmed Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title_short Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
title_sort bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide bpc 157, l-name and l-arginine
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305534/
https://www.ncbi.nlm.nih.gov/pubmed/30598581
http://dx.doi.org/10.3748/wjg.v24.i47.5366
work_keys_str_mv AT amicfedor bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT drmicdomagoj bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT biliczdenko bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT krezicivan bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT zizekhelena bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT peklicmarina bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT klicekrobert bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT pajtakalen bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT amicenio bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT vidovictinka bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT rakicmislav bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT milkovicperisamarija bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT horvatpavlovkatarina bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT kokotantonio bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT tvrdeicante bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT bobanblagaicalenka bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT zovakmario bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT seiwerthsven bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine
AT sikiricpredrag bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine